ConductScience.org, home

Paper41219185

Targeting polyamine metabolism and ferroptosis enhances the efficacy of KRAS-targeted therapy depending on KEAP1 status.

Bian Y and 15 others. Nat Commun, 2025. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Targeting polyamine metabolism and ferroptosis enhances the efficacy of KRAS-targeted therapy depending on KEAP1 status. Papers, record 41219185. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41219185

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Targeting polyamine metabolism and ferroptosis enhances the efficacy of KRAS-targeted therapy depending on KEAP1 status.
PubMed
Journal
Nat Commun
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
1.53, provisional
iCite
Revised in PubMed
2025-11-14
PubMed

Authors16

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bian YYunyi
2Shan GGuangyaohttps://orcid.org/0000-0002-2993-5817
3Bi GGuoshuhttps://orcid.org/0000-0003-2187-5271
4Xu ZZhijiehttps://orcid.org/0000-0003-2047-883X
5Liang JJiaqihttps://orcid.org/0000-0002-4738-4238
6Yan YYuanliang
7Guo WWeihttps://orcid.org/0000-0001-8302-8292
8Sui QQihai
9Yi YYanjun
10Shi HHaochun
11Lu TTao
12Zhang HHuan
13Wang QQunhttps://orcid.org/0000-0003-4853-1727
14Fan HHonghttps://orcid.org/0000-0002-2005-1150
15Jiang WWeihttps://orcid.org/0000-0003-0904-3990
16Zhan CChenghttps://orcid.org/0000-0001-8745-9276

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
FerroptosisMajor topic
Proto-Oncogene Proteins p21(ras)Major topic
PolyaminesMajor topic
Kelch-Like ECH-Associated Protein 1Major topic
Animals
Humans
Mice
Cell Line, Tumor
Xenograft Model Antitumor Assays
NF-E2-Related Factor 2
Drug Resistance, Neoplasm
Mutation
Molecular Targeted Therapy

Source PubMed

Download CSV of topics

References82

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138217522Cellular metabolism: A key player in cancer ferroptosis.Cancer Commun (Lond)2024https://conductscience.org/library/papers/38217522PubMed
233820777Mechanisms of Resistance to KRASG12C-Targeted Therapy.Cancer Discov2021https://conductscience.org/library/papers/33820777PubMed
339121480Epigenetic and Oncogenic Inhibitors Cooperatively Drive Differentiation and Kill KRAS-Mutant Colorectal Cancers.Cancer Discov2024https://conductscience.org/library/papers/39121480PubMed
437184371Retinol Saturase Mediates Retinoid Metabolism to Impair a Ferroptosis Defense System in Cancer Cells.Cancer Res2023https://conductscience.org/library/papers/37184371PubMed
533870211The Metabolic Landscape of RAS-Driven Cancers from biology to therapy.Nat Cancer2021https://conductscience.org/library/papers/33870211PubMed
68500690Spermidine/spermine N1-acetyltransferase--the turning point in polyamine metabolism.FASEB J1993https://conductscience.org/library/papers/8500690PubMed
79852135
The identification of a cis-element and a trans-acting factor involved in the response to polyamines and polyamine analogues in the regulation of the human spermidine/spermine N1-acetyltransferase gene transcription.
J Biol Chem1998https://conductscience.org/library/papers/9852135PubMed
829577948l-Arginine induces antioxidant response to prevent oxidative stress via stimulation of glutathione synthesis and activation of Nrf2 pathway.Food Chem Toxicol2018https://conductscience.org/library/papers/29577948PubMed
926403645Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells.Hepatology2016https://conductscience.org/library/papers/26403645PubMed
1024066166Insight into the intermolecular recognition mechanism between Keap1 and IKKβ combining homology modelling, protein-protein docking, molecular dynamics simulations and virtual alanine mutation.PLoS One2013https://conductscience.org/library/papers/24066166PubMed
1122239440Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy.Expert Opin Ther Targets2012https://conductscience.org/library/papers/22239440PubMed
1239317105Targeting ALDH1A1 to enhance the efficacy of KRAS-targeted therapy through ferroptosis.Redox Biol2024https://conductscience.org/library/papers/39317105PubMed
1336657446Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study.Cell Rep Med2023https://conductscience.org/library/papers/36657446PubMed
1435922812Targeting KRAS mutant cancers: from druggable therapy to drug resistance.Mol Cancer2022https://conductscience.org/library/papers/35922812PubMed
1527698118Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses.Proc Natl Acad Sci U S A2016https://conductscience.org/library/papers/27698118PubMed
1618241672Changes in mRNA and protein levels of human HtrA1, HtrA2 and HtrA3 in ovarian cancer.Clin Biochem2008https://conductscience.org/library/papers/18241672PubMed
1724142871The emerging role of the Nrf2-Keap1 signaling pathway in cancer.Genes Dev2013https://conductscience.org/library/papers/24142871PubMed
1825814555Systematic analysis of BRAF(V600E) melanomas reveals a role for JNK/c-Jun pathway in adaptive resistance to drug-induced apoptosis.Mol Syst Biol2015https://conductscience.org/library/papers/25814555PubMed
1932955176KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors.N Engl J Med2020https://conductscience.org/library/papers/32955176PubMed
2036707233Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade.Gut2023https://conductscience.org/library/papers/36707233PubMed

See all 82 referencesDownload CSV of references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42935189[From driver gene mutations to cell death crosstalk: Ferroptosis regulatory networks and prospects for targeted cancer therapy].Zhong Nan Da Xue Xue Bao Yi Xue Ban2026https://conductscience.org/library/papers/42935189PubMed
42919317ERK/GATAD2A/SAA1 axis drives osimertinib resistance via NF-κB and macrophage reprogramming in EGFR-mutated lung adenocarcinoma.J Exp Clin Cancer Res2026https://conductscience.org/library/papers/42919317PubMed
42866008Palmatine Induces TNNT1 Ubiquitination and Degradation to Potentiate Ferroptosis Sensitivity in Hepatocellular Carcinoma.J Clin Transl Hepatol2026https://conductscience.org/library/papers/42866008PubMed
42855676Polyamine metabolism in ischemia reperfusion injury: common mitochondrial mechanisms and organ-specific differences.J Transl Med2026https://conductscience.org/library/papers/42855676PubMed
42757463Arginine metabolism, polyamine homeostasis and ferroptosis in cancer: Molecular links and therapeutic opportunities (Review).Mol Med Rep2026https://conductscience.org/library/papers/42757463PubMed
42630362
Gene signatures of palmitoylation and fatty acid metabolism predict prognosis and immunotherapy response in breast cancer patients by machine learning, single-cell analysis, and experimental validation.
Front Pharmacol2026https://conductscience.org/library/papers/42630362PubMed
42610639Carrier-Free Berberine/Nitidine Chloride Self-Assembled Nanoparticles Induce Ferroptosis to Overcome Bortezomib Resistance in Multiple Myeloma.Adv Sci (Weinh)2026https://conductscience.org/library/papers/42610639PubMed
42099806Iron: Regulation, redox homeostasis, and ferroptosis in cancer.Ferroptosis Oxid Stress2026https://conductscience.org/library/papers/42099806PubMed
42009648Unveiling DEFB1 as a novel driver and promising therapeutic target in lung adenocarcinoma.Cell Death Dis2026https://conductscience.org/library/papers/42009648PubMed
41998662MXD4 enhances resistance to KRAS G12C-targeted therapy in lung adenocarcinoma by suppressing ACSL4-mediated ferroptosis.Respir Res2026https://conductscience.org/library/papers/41998662PubMed
41735603Translating ferroptosis into oncology: challenges, opportunities and future directions.Nat Rev Clin Oncol2026https://conductscience.org/library/papers/41735603PubMed

Download CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
JUN3725PubTator's text mininghttps://conductscience.org/library/genes/3725NCBI Gene
KEAP19817PubTator's text mininghttps://conductscience.org/library/genes/9817NCBI Gene
KRAS3845PubTator's text mininghttps://conductscience.org/library/genes/3845NCBI Gene
MAPK85599PubTator's text mininghttps://conductscience.org/library/genes/5599NCBI Gene
NFE2L24780PubTator's text mininghttps://conductscience.org/library/genes/4780NCBI Gene
SAT16303PubTator's text mininghttps://conductscience.org/library/genes/6303NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41219185

GET https://conductscience.org/api/papers/v1/41219185/references?page=2